Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Mechanism of action of parathyroid hormone‐induced proteoglycan synthesis in the growth plate chondrocyte

View through CrossRef
AbstractIn the growth plate chondrocyte, parathyroid hormone (PTH) stimulates phosphoinositol 4, 5 bisphosphate (PIP2) degradation, which results in the rapid production of inositol (1,4,5) triphosphate (IP3). IP3 induced the release of calcium from an intracellular store, which caused a rapid increase in the cytosolic ionized calcium concentration. Parathyroid hormone also induced a 30–50% increase in proteoglycan synthesis. Phorbol esters, which pharmacologically activate protein kinase C, resulted in a 70–80% increase in proteoglycan synthesis. Treatment of the chondrocytes with retinoic acid (0.2 μM) inhibited the parathyroid hormone and phorbol ester‐induced increase in intracellular ionized calcium and the increase in proteoglycan synthesis. From this data we postulate that the stimulation of proteoglycan synthesis in growth plate chondrocytes by PTH is mediated by the breakdown of membrane phosphoinositides, which results in the production of IP3 and an increase in ionized intracellular calcium. It is suggested that the degradation of membrane phosphoinositides also results in production of diacylglycerol and, thereby, an activation of protein kinase C, which has a large stimulatory effect on proteoglycan synthesis. The increase in cytosolic calcium most likely acts synergetically with diacylglycerol to activate protein kinase C. Retinoic acid blocks the effect of PTH and phorbol ester‐induced proteoglycan synthesis and may act through the inhibition of protein kinase C. The overall effect of PTH on the growth plate chondrocyte appears to be a stimulation of proteoglycan synthesis that is mediated by the degradation products of membrane phosphoinositides.
Title: Mechanism of action of parathyroid hormone‐induced proteoglycan synthesis in the growth plate chondrocyte
Description:
AbstractIn the growth plate chondrocyte, parathyroid hormone (PTH) stimulates phosphoinositol 4, 5 bisphosphate (PIP2) degradation, which results in the rapid production of inositol (1,4,5) triphosphate (IP3).
IP3 induced the release of calcium from an intracellular store, which caused a rapid increase in the cytosolic ionized calcium concentration.
Parathyroid hormone also induced a 30–50% increase in proteoglycan synthesis.
Phorbol esters, which pharmacologically activate protein kinase C, resulted in a 70–80% increase in proteoglycan synthesis.
Treatment of the chondrocytes with retinoic acid (0.
2 μM) inhibited the parathyroid hormone and phorbol ester‐induced increase in intracellular ionized calcium and the increase in proteoglycan synthesis.
From this data we postulate that the stimulation of proteoglycan synthesis in growth plate chondrocytes by PTH is mediated by the breakdown of membrane phosphoinositides, which results in the production of IP3 and an increase in ionized intracellular calcium.
It is suggested that the degradation of membrane phosphoinositides also results in production of diacylglycerol and, thereby, an activation of protein kinase C, which has a large stimulatory effect on proteoglycan synthesis.
The increase in cytosolic calcium most likely acts synergetically with diacylglycerol to activate protein kinase C.
Retinoic acid blocks the effect of PTH and phorbol ester‐induced proteoglycan synthesis and may act through the inhibition of protein kinase C.
The overall effect of PTH on the growth plate chondrocyte appears to be a stimulation of proteoglycan synthesis that is mediated by the degradation products of membrane phosphoinositides.

Related Results

Pseudohypoparathyroidism versus signaling disorder: A case report
Pseudohypoparathyroidism versus signaling disorder: A case report
Pseudohypoparathyroidism is a terminology used to describe a group of metabolic disorders characterized by parathyroid hormone resistance. Patients with pseudohypoparathyroidism ha...
Primary and Metastatic Parathyroid Malignancies: A Rare or Underdiagnosed Condition?
Primary and Metastatic Parathyroid Malignancies: A Rare or Underdiagnosed Condition?
Objective: Parathyroid gland malignancies are considered rare. The most common of these tumor types is primary parathyroid carcinoma. Metastatic spread from other...
Deferoxamine Alleviates Osteoarthritis by Inhibiting Chondrocyte Ferroptosis and Activating the Nrf2 Pathway
Deferoxamine Alleviates Osteoarthritis by Inhibiting Chondrocyte Ferroptosis and Activating the Nrf2 Pathway
Objective: Osteoarthritis (OA) is a common disease with a complex pathology including mechanical load, inflammation, and metabolic factors. Chondrocyte ferroptosis contributes to O...
Renal Phosphate Loss in Long-Term Kidney Transplantation
Renal Phosphate Loss in Long-Term Kidney Transplantation
Summary Background and objectives Renal phosphate wasting occurs early postkidney transplantation as a result of an accumulation of parathyroid h...
Fluoride Therapy and Parathyroid Hormone Activity in Osteoporosis
Fluoride Therapy and Parathyroid Hormone Activity in Osteoporosis
1. To determine the relationships between parathyroid hormone activity and long-term sodium fluoride therapy in osteoporosis, cytochemical bioassays (for biologically active parath...
Cross-Expression of Thymic and Parathyroid Hormone Receptors Supports the Hypothesis of a Parathyroid–Thymus Port System
Cross-Expression of Thymic and Parathyroid Hormone Receptors Supports the Hypothesis of a Parathyroid–Thymus Port System
The thymus and parathyroid glands share a common embryological origin from the third pharyngeal pouch, yet their potential morphological and functional interconnections remain insu...

Back to Top